P-BIO, Biosurfit, CEiiA, CellmAbs, Crioestaminal, Genibet, HeartGenetics, Immunethep, LiMM, Matera, MyBiome, Nano4, Stab Vida, SWORD Health, TonicApp, MCTES
LAQV-REQUIMTE, Universidade de Aveiro Looking for a partner able to replicate Covid-19 virus to be attenuated by the novel process and another partner to produce and test the vaccine in vitro (mammalian cells and other if considered more adequate/pertinent)
Instituto Nacional de Saúde Dr. Ricardo Jorge and Direção Geral da Saúde. Epiconcept, France (coordinators) Public health Institute Albania Public Health England University of Oxford/RCGP RSC, UK Université Sorbonne, France Institut Pasteur, France Santé Publique France Université de Corse Pascal Paoli, France Vienna Vaccine Safety Initiative (ViVI), Germany HPSC, Ireland Lithuanian University of Health Sciences, Lithuania NIVEL, The Netherlands RIVM, The Netherlands INS Ricardo Jorge, Portugal DGS Portugal INCDMIC Cantacuzino, Romania Public Health Scotland ISCIII National Centre for Epidemiology, Spain ISCIII National Centre for Microbiology, Spain ISPL-Navarra, Spain Public Health Agency, Sweden
Teste
Vacinas
